Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4528700
Max Phase: Preclinical
Molecular Formula: C24H19N3O2
Molecular Weight: 381.44
Molecule Type: Unknown
Associated Items:
ID: ALA4528700
Max Phase: Preclinical
Molecular Formula: C24H19N3O2
Molecular Weight: 381.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CCNc1nc(-c2ccccc2)c(Cc2c(O)ccc3ccccc23)c(=O)[nH]1
Standard InChI: InChI=1S/C24H19N3O2/c1-2-14-25-24-26-22(17-9-4-3-5-10-17)20(23(29)27-24)15-19-18-11-7-6-8-16(18)12-13-21(19)28/h1,3-13,28H,14-15H2,(H2,25,26,27,29)
Standard InChI Key: SMFXCGOHISIRNU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 381.44 | Molecular Weight (Monoisotopic): 381.1477 | AlogP: 3.93 | #Rotatable Bonds: 5 |
Polar Surface Area: 78.01 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.95 | CX Basic pKa: 2.10 | CX LogP: 3.68 | CX LogD: 3.58 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.46 | Np Likeness Score: -0.51 |
1. Botta L, Filippi S, Bizzarri BM, Meschini R, Caputo M, Proietti-De-Santis L, Iside C, Nebbioso A, Gualandi G, Saladino R.. (2019) Oxidative nucleophilic substitution selectively produces cambinol derivatives with antiproliferative activity on bladder cancer cell lines., 29 (1): [PMID:30442421] [10.1016/j.bmcl.2018.11.006] |
Source(1):